Total Debt Summary of GuiZhou SanLi Pharmaceutical Co.,Ltd

GuiZhou SanLi Pharmaceutical Co.,Ltd's latest annual total debt in 2023 was 609.95 Million CNY , up 196.57% from previous year.
GuiZhou SanLi Pharmaceutical Co.,Ltd's latest quarterly total debt in 2024 Q3 was 531.99 Million CNY , down -16.45% from previous quarter.
GuiZhou SanLi Pharmaceutical Co.,Ltd reported annual total debt of 205.66 Million CNY in 2022, up 2.83% from previous year.
GuiZhou SanLi Pharmaceutical Co.,Ltd reported annual total debt of 200 Million CNY in 2021, down 0.0% from previous year.
GuiZhou SanLi Pharmaceutical Co.,Ltd reported quarterly total debt of 637.13 Million CNY for 2024 Q2, up 6.26% from previous quarter.
GuiZhou SanLi Pharmaceutical Co.,Ltd reported quarterly total debt of 599.6 Million CNY for 2024 Q1, down -1.7% from previous quarter.

Annual Total Debt Chart of GuiZhou SanLi Pharmaceutical Co.,Ltd (2023 - 2013)

Historical Annual Total Debt of GuiZhou SanLi Pharmaceutical Co.,Ltd (2023 - 2013)

Year	Total Debt	Total Debt Growth
2023	609.95 Million CNY	196.57%
2022	205.66 Million CNY	2.83%
2021	200 Million CNY	0.0%
2020	200 Million CNY	0.0%
2019	- CNY	0.0%
2018	- CNY	0.0%
2017	- CNY	0.0%
2016	- CNY	0.0%
2015	- CNY	-100.0%
2014	60.6 Million CNY	95.48%
2013	31 Million CNY	0.0%

Year	Total Debt	Total Debt Growth
2024 Q3	531.99 Million CNY	-16.45%
2024 Q2	637.13 Million CNY	6.26%
2024 Q1	599.6 Million CNY	-1.7%
2023 Q3	205.2 Million CNY	-0.11%
2023 Q2	205.42 Million CNY	-0.05%
2023 Q1	205.53 Million CNY	-0.07%
2023 FY	609.95 Million CNY	196.57%
2023 Q4	609.95 Million CNY	197.25%
2022 FY	205.66 Million CNY	2.83%
2022 Q4	205.66 Million CNY	0.33%
2022 Q3	205 Million CNY	0.0%
2022 Q2	205 Million CNY	2.5%
2022 Q1	200 Million CNY	0.0%
2021 Q2	180 Million CNY	-10.0%
2021 Q1	200 Million CNY	0.0%
2021 FY	200 Million CNY	0.0%
2021 Q3	180 Million CNY	0.0%
2021 Q4	200 Million CNY	11.11%
2020 Q4	200 Million CNY	100.0%
2020 Q1	- CNY	0.0%
2020 FY	200 Million CNY	0.0%
2020 Q2	202.1 Million CNY	0.0%
2020 Q3	100 Million CNY	-50.52%
2019 Q4	- CNY	0.0%
2019 Q2	- CNY	0.0%
2019 FY	- CNY	0.0%
2019 Q1	- CNY	0.0%
2018 Q2	- CNY	0.0%
2018 Q4	- CNY	0.0%
2018 FY	- CNY	0.0%
2018 Q1	- CNY	0.0%
2017 FY	- CNY	0.0%
2017 Q4	- CNY	0.0%
2017 Q1	- CNY	0.0%
2017 Q3	- CNY	0.0%
2016 Q1	- CNY	0.0%
2016 Q3	- CNY	0.0%
2016 FY	- CNY	0.0%
2016 Q2	- CNY	0.0%
2016 Q4	- CNY	0.0%
2015 Q2	28.4 Million CNY	-14.97%
2015 Q4	- CNY	0.0%
2015 Q3	- CNY	-100.0%
2015 FY	- CNY	-100.0%
2015 Q1	33.4 Million CNY	-44.88%
2014 Q3	60.6 Million CNY	0.0%
2014 Q1	- CNY	0.0%
2014 Q4	60.6 Million CNY	0.0%
2014 FY	60.6 Million CNY	95.48%
2013 FY	31 Million CNY	0.0%

Peer Total Debt Comparison of GuiZhou SanLi Pharmaceutical Co.,Ltd

Name	Total Debt	Total Debt Difference
Beijing Tiantan Biological Products Co., Ltd.	147.06 Million CNY	-314.749%
JiangSu WuZhong Pharmaceutical Development Co., Ltd.	1.79 Billion CNY	66.007%
Jinyu Bio-technology Co., Ltd.	4.26 Million CNY	-14196.557%
Vcanbio Cell & Gene Engineering Corp., Ltd	115.87 Million CNY	-426.382%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong	4.39 Billion CNY	86.132%
Zhejiang Ausun Pharmaceutical Co., Ltd.	412.92 Million CNY	-47.717%
DaShenLin Pharmaceutical Group Co., Ltd.	10.66 Billion CNY	94.283%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.	399.07 Million CNY	-52.842%
Pulike Biological Engineering, Inc.	2.05 Million CNY	-29619.356%
Beijing Konruns Pharmaceutical Co.,Ltd.	149.78 Million CNY	-307.231%
Shanghai Hile Bio-Technology Co., Ltd.	50.82 Million CNY	-1100.026%
Qingdao Vland Biotech INC.	733.83 Million CNY	16.881%
Zhejiang Shouxiangu Pharmaceutical Co., Ltd.	748.39 Million CNY	18.498%
Aurisco Pharmaceutical Co.,Ltd.	116.88 Million CNY	-421.854%
Zhejiang East Asia Pharmaceutical Co., Ltd.	706.92 Million CNY	13.717%
Hainan Huluwa Pharmaceutical Group Co., Ltd.	1.28 Billion CNY	52.407%
Mabwell (Shanghai) Bioscience Co., Ltd.	1.29 Billion CNY	52.813%
Beijing Hotgen Biotech Co., Ltd.	15.25 Million CNY	-3898.227%
Assure Tech (Hangzhou) Co., Ltd.	15.58 Million CNY	-3814.474%
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.	1 Billion CNY	39.577%
Cabio Biotech (Wuhan) Co., Ltd.	12.76 Million CNY	-4678.997%
Shanghai Shen Lian Biomedical Corporation	1.25 Million CNY	-48657.758%
Nanjing Vazyme Biotech Co., Ltd.	1.28 Billion CNY	52.607%
Shandong Kexing Bioproducts Co,.Ltd	1.11 Billion CNY	45.347%
Shanghai Junshi Biosciences Co., Ltd.	1.78 Billion CNY	65.854%
Shanghai Model Organisms Center, Inc.	94.75 Million CNY	-543.716%
Suzhou Zelgen Biopharmaceuticals Co., Ltd.	886.42 Million CNY	31.189%
Xiamen Amoytop Biotech Co., Ltd.	7.92 Million CNY	-7597.591%
Novogene Co., Ltd.	42.17 Million CNY	-1346.103%
Shanghai ZJ Bio-Tech Co., Ltd.	7.45 Million CNY	-8082.889%
Chengdu Olymvax Biopharmaceuticals Inc.	237.6 Million CNY	-156.711%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd	50.02 Million CNY	-1119.254%
Shanghai Haohai Biological Technology Co., Ltd.	407.94 Million CNY	-49.518%
Jiangsu Bioperfectus Technologies Co., Ltd.	173.45 Million CNY	-251.651%
Jiangsu Aidea Pharmaceutical Co., Ltd.	412.3 Million CNY	-47.94%
Chengdu Easton Biopharmaceuticals Co., Ltd.	223.48 Million CNY	-172.935%
Sinocelltech Group Limited	2.74 Billion CNY	77.788%
Wuhan Keqian Biology Co.,Ltd	293.5 Million CNY	-107.816%
Shanghai Allist Pharmaceuticals Co., Ltd.	1.82 Million CNY	-33356.229%
Anhui Huaheng Biotechnology Co., Ltd.	1.24 Billion CNY	51.072%
Youcare Pharmaceutical Group Co., Ltd.	462.91 Million CNY	-31.765%
Jiangsu gdk Biotechnology Co., Ltd.	64.05 Million CNY	-852.203%
Beijing Kawin Technology Share-Holding Co., Ltd.	54.92 Million CNY	-1010.563%
Hangzhou Biotest Biotech Co.,Ltd.	3.03 Million CNY	-19971.254%

Global Stocks Search

GuiZhou SanLi Pharmaceutical Co.,Ltd (603439.SS)

Total Debt Summary of GuiZhou SanLi Pharmaceutical Co.,Ltd

Annual Total Debt Chart of GuiZhou SanLi Pharmaceutical Co.,Ltd (2023 - 2013)

Historical Annual Total Debt of GuiZhou SanLi Pharmaceutical Co.,Ltd (2023 - 2013)

Peer Total Debt Comparison of GuiZhou SanLi Pharmaceutical Co.,Ltd